E-LIB Suche - Ergebnisse für: Kamal-Bahl, S.

1

EE158 Healthcare Resource Utilization and Costs Among Medic..:

Huntington, S. ; Manzoor, B.S. ; Jawaid, D....
Value in Health. 26 (2023) 6 - p. S88-S89 , 2023

Link: https://doi.org/10.1016/..

2

CO137 Real-World Outcomes Associated with Bezlotoxumab Use ..:

Dubberke, E ; Puckett, J ; Obi, EN...
Value in Health. 25 (2022) 7 - p. S330 , 2022

Link: https://doi.org/10.1016/..

3

PMU49 Patient Heterogeneity and the Limitations of One-Size..:

Kamal-Bahl, S. ; Puckett, J. ; Willke, R.
Value in Health. 24 (2021) - p. S153 , 2021

Link: https://doi.org/10.1016/..

4

PMU51 IMPACT OF TREATMENT DELAYS ON PATIENT OUTCOMES AND IM..:

Dougherty, S. ; Soh, C. ; Vandigo, J..
Value in Health. 22 (2019) - p. S258 , 2019

Link: https://doi.org/10.1016/..

5

PCN402 THE CLINICAL AND ECONOMIC CONSEQUENCES OF DELAYS IN ..:

Leinwand, B. ; Sollano, J. ; Doherty, J.P....
Value in Health. 22 (2019) - p. S514 , 2019

Link: https://doi.org/10.1016/..

6

Economic Considerations In Clinical Guidelines - Are Patien..:

Subedi, P ; Kamal-Bahl, S
Value in Health. 18 (2015) 7 - p. A565-A566 , 2015

Link: https://doi.org/10.1016/..

7

Financing a Cure for Diabetes In a multi-Payer environment:

Basu, A. ; Kamal-Bahl, S. ; Subedi, P.
Value in Health. 18 (2015) 3 - p. A69-A70 , 2015

Link: https://doi.org/10.1016/..

8

Challenges Faced By Decision Makers From Middle Income Coun..:

Drummond, M. ; Augustovski, F. ; Kalo, Z....
Value in Health. 17 (2014) 3 - p. A26 , 2014

Link: https://doi.org/10.1016/..

9

Bridging HTA Agencies Across Europe: A Systematic Approach ..:

Nagy, L. ; Kamal-Bahl, S. ; Brandtmüller, A.
Value in Health. 16 (2013) 3 - p. A268 , 2013

Link: https://doi.org/10.1016/..

10

PCV56 PERSISTENCE WITH NEWLY-INITIATED EXTENDED-RELEASE NIA..:

Kamal-Bahl, S ; Burke, T ; Watson, D.
Value in Health. 9 (2006) 3 - p. A135-A136 , 2006

Link: https://doi.org/10.1016/..

11

PCV26 MEDICARE EXPENDITURES IN RELATION TO FUNCTIONAL HEALT..:

Singhal, PK ; Stuart, B ; Menis, M.
Value in Health. 7 (2004) 3 - p. 325-326 , 2004

Link: https://doi.org/10.1016/..

12

ASI: CHANGES IN FUNCTIONAL DISABILITY LEVELS AND MEDICAL EX..:

Kamal-Bahl, S ; Stuart, B ; Briesacher, B.
Value in Health. 6 (2003) 3 - p. 195 , 2003

Link: https://doi.org/10.1016/..

13

PCN9 PHARMACOECONOMIC ANALYSES OF AVAILABLE CHEMOTHERAPEUTI..:

Kamal-Bahl, S ; Doshi, JA ; Grossman, P
Value in Health. 5 (2002) 3 - p. 197 , 2002

Link: https://doi.org/10.1016/..

14

PID2: PHARMACOECONOMIC EVALUATION OF IMMUNOPROPHYLAXIS FOR ..:

Doshi, J ; Kamal-Bahl, S
Value in Health. 3 (2000) 5 - p. 321 , 2000

Link: https://doi.org/10.1016/..

15

PCV27 AN ECONOMIC ANALYSIS OF EZETIMIBE/SIMVASTATIN COMPARE..:

Nag, SS ; Sajjan, SG ; Kamal Bahl, S...
Value in Health. 8 (2005) 3 - p. 268-269 , 2005

Link: https://doi.org/10.1016/..